286 related articles for article (PubMed ID: 25487403)
21. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.
Aldinucci D; Gloghini A; Pinto A; De Filippi R; Carbone A
J Pathol; 2010 Jul; 221(3):248-63. PubMed ID: 20527019
[TBL] [Abstract][Full Text] [Related]
22. Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations.
Agaimy A; Wild V; Märkl B; Wachter DL; Hartmann A; Rosenwald A; Ihrler S
Am J Surg Pathol; 2015 Sep; 39(9):1206-12. PubMed ID: 25929348
[TBL] [Abstract][Full Text] [Related]
23. Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma.
Hansen HP; Engels HM; Dams M; Paes Leme AF; Pauletti BA; Simhadri VL; Dürkop H; Reiners KS; Barnert S; Engert A; Schubert R; Quondamatteo F; Hallek M; Pogge von Strandmann E
J Pathol; 2014 Mar; 232(4):405-14. PubMed ID: 24659185
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin's disease: classification and differential diagnosis.
Harris NL
Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
[TBL] [Abstract][Full Text] [Related]
25. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
26. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment.
Steidl C; Connors JM; Gascoyne RD
J Clin Oncol; 2011 May; 29(14):1812-26. PubMed ID: 21483001
[TBL] [Abstract][Full Text] [Related]
28. The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
Brown P; Marafioti T; Kusec R; Banham AH
J Mol Histol; 2005 May; 36(4):249-56. PubMed ID: 16200457
[TBL] [Abstract][Full Text] [Related]
29. [Immunophenotype and differential diagnosis of Hodgkin's lymphoma].
Liu Y; Zhuang H; Liao X; Luo X; Luo D; Cai X
Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):524-7. PubMed ID: 12482349
[TBL] [Abstract][Full Text] [Related]
30. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
32. Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant.
Drakos E; Rassidakis GZ; Leventaki V; Cotta CV; Vega F; Medeiros LJ
Am J Surg Pathol; 2009 Nov; 33(11):1725-31. PubMed ID: 19730363
[TBL] [Abstract][Full Text] [Related]
33. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?
Harris NL
Ann Oncol; 1998; 9 Suppl 5():S45-56. PubMed ID: 9926237
[TBL] [Abstract][Full Text] [Related]
34. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.
Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R
Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195
[TBL] [Abstract][Full Text] [Related]
35. Immune reactions in classical Hodgkin's lymphoma.
Poppema S; Potters M; Emmens R; Visser L; van den Berg A
Semin Hematol; 1999 Jul; 36(3):253-9. PubMed ID: 10462325
[TBL] [Abstract][Full Text] [Related]
36. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma.
Schmitz R; Stanelle J; Hansmann ML; Küppers R
Annu Rev Pathol; 2009; 4():151-74. PubMed ID: 19400691
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
[TBL] [Abstract][Full Text] [Related]
39. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts.
Atayar C; Poppema S; Visser L; van den Berg A
J Pathol; 2006 Feb; 208(3):423-30. PubMed ID: 16353293
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.
Wang S; Medeiros LJ; Xu-Monette ZY; Zhang S; O'Malley DP; Orazi A; Zuo Z; Bueso-Ramos CE; Yin CC; Liu Z; Miranda RN; Young KH
Ann Diagn Pathol; 2014 Aug; 18(4):203-9. PubMed ID: 24852241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]